DD296843A5 - Monoklonale antikoerper zur indukzierung von tobranz - Google Patents

Monoklonale antikoerper zur indukzierung von tobranz Download PDF

Info

Publication number
DD296843A5
DD296843A5 DD90341218A DD34121890A DD296843A5 DD 296843 A5 DD296843 A5 DD 296843A5 DD 90341218 A DD90341218 A DD 90341218A DD 34121890 A DD34121890 A DD 34121890A DD 296843 A5 DD296843 A5 DD 296843A5
Authority
DD
German Democratic Republic
Prior art keywords
exhaustive
antibody
monoclonal
tolerance
antigen
Prior art date
Application number
DD90341218A
Other languages
German (de)
English (en)
Inventor
Stephen P Cobbold
Herman Waldmann
Original Assignee
�������k��������@����k��
Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������k��������@����k��, Kk filed Critical �������k��������@����k��
Publication of DD296843A5 publication Critical patent/DD296843A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2815—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DD90341218A 1989-05-31 1990-05-31 Monoklonale antikoerper zur indukzierung von tobranz DD296843A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898912497A GB8912497D0 (en) 1989-05-31 1989-05-31 Monoclonal antibodies

Publications (1)

Publication Number Publication Date
DD296843A5 true DD296843A5 (de) 1991-12-19

Family

ID=10657649

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90341218A DD296843A5 (de) 1989-05-31 1990-05-31 Monoklonale antikoerper zur indukzierung von tobranz

Country Status (19)

Country Link
EP (1) EP0474691B1 (pt)
JP (1) JP2763197B2 (pt)
KR (1) KR0183029B1 (pt)
AT (1) ATE145246T1 (pt)
AU (1) AU657255B2 (pt)
CA (1) CA2055615C (pt)
DD (1) DD296843A5 (pt)
DE (1) DE69029134T2 (pt)
DK (1) DK0474691T3 (pt)
ES (1) ES2096588T3 (pt)
GB (1) GB8912497D0 (pt)
HU (1) HUT61341A (pt)
IE (1) IE80735B1 (pt)
IL (1) IL94566A0 (pt)
MY (1) MY135673A (pt)
NZ (1) NZ233889A (pt)
PT (1) PT94214B (pt)
WO (1) WO1990015152A1 (pt)
ZA (1) ZA904174B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9100741D0 (en) * 1991-01-14 1991-02-27 Univ London Treatment of disease
US6136310A (en) 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
WO1994004188A1 (en) * 1992-08-21 1994-03-03 Genentech, Inc. Method for treating an lfa-1-mediated disorder
US6270766B1 (en) 1992-10-08 2001-08-07 The Kennedy Institute Of Rheumatology Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
WO1996036359A1 (en) * 1995-05-18 1996-11-21 Ortho Pharmaceutical Corporation Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies
ES2282133T3 (es) 1999-08-24 2007-10-16 Medarex, Inc. Anticuerpos frente a la ctla-4 humano y sus usos.
US7011952B2 (en) 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
DE60136272D1 (de) 2000-04-29 2008-12-04 Univ Iowa Res Found Diagnostika und therapeutika für makula degeneration erkrankungen
JP4448906B2 (ja) * 2001-06-14 2010-04-14 イシス イノベーション リミテッド Ｃｄ４特異的抗体ｔｒｘ１およびその使用
US7541443B2 (en) * 2001-06-14 2009-06-02 Tolerrx, Inc. Anti-CD4 antibodies
EP1460088A1 (en) 2003-03-21 2004-09-22 Biotest AG Humanized anti-CD4 antibody with immunosuppressive properties
GB0314461D0 (en) * 2003-06-20 2003-07-23 Isis Innovation Suppression of transplant rejection
AU2005258276A1 (en) * 2004-06-22 2006-01-05 Tolerrx, Inc. Optimized dosing with anti-CD4 antibodies for tolerance induction in primates
AU2009235622C9 (en) 2008-03-13 2015-07-02 Biotest Ag Agent for treating disease
BRPI0909179A2 (pt) 2008-03-13 2015-08-25 Biotest Ag Composição farmacêutica, e, método de tratamento de uma doença autoimune.
JP5597553B2 (ja) 2008-03-13 2014-10-01 バイオテスト・アクチエンゲゼルシヤフト 疾患治療剤
CN102112491A (zh) * 2008-06-06 2011-06-29 贝勒研究院 抗-cd8抗体阻断细胞毒素效应物的引发并导致调节性cd8+t细胞的产生
TW201016233A (en) * 2008-07-15 2010-05-01 Genentech Inc Methods of treating autoimmune diseases using CD4 antibodies
GB0920944D0 (en) 2009-11-30 2010-01-13 Biotest Ag Agents for treating disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608068D0 (en) * 1986-04-02 1986-05-08 Cobbold S P Monoclonal antibodies

Also Published As

Publication number Publication date
WO1990015152A1 (en) 1990-12-13
NZ233889A (en) 1997-06-24
DK0474691T3 (da) 1996-12-02
MY135673A (en) 2008-06-30
AU657255B2 (en) 1995-03-09
IL94566A0 (en) 1991-03-10
HU905134D0 (en) 1992-02-28
KR0183029B1 (ko) 1999-04-01
ZA904174B (en) 1992-02-26
IE901949L (en) 1990-11-30
PT94214B (pt) 1997-03-31
GB8912497D0 (en) 1989-07-19
DE69029134D1 (de) 1996-12-19
ATE145246T1 (de) 1996-11-15
ES2096588T3 (es) 1997-03-16
DE69029134T2 (de) 1997-03-06
CA2055615A1 (en) 1990-12-13
PT94214A (pt) 1991-02-08
IE80735B1 (en) 1998-12-30
HUT61341A (en) 1992-12-28
CA2055615C (en) 2001-07-17
JPH04505919A (ja) 1992-10-15
AU5725890A (en) 1991-01-07
EP0474691A1 (en) 1992-03-18
JP2763197B2 (ja) 1998-06-11
EP0474691B1 (en) 1996-11-13

Similar Documents

Publication Publication Date Title
DD296843A5 (de) Monoklonale antikoerper zur indukzierung von tobranz
US6056956A (en) Non-depleting anti-CD4 monoclonal antibodies and tolerance induction
DE69733960T2 (de) Verwendung von Antikörpern gegen CD45RO Leukozytenantigen zur Immunmodulation
Miler et al. The immunological significance of the thymus
DE69713499T3 (de) Verfahren zur inhibierung der immunreaktion durch blockierung der gp39/cd40 und ctla4/cd28/b7 routen und zusammensetzung zu deren verwendung
DE69533984T2 (de) Verfahren zur anregung von t-zelltoleranz gegen ein gewebe- oder organtransplantat
Qin et al. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction
EP1115427B1 (de) Verwendung von tumorzellen zeitversetzt in kombination mit intakten antikörpern zur immunisierung
DE69916807T2 (de) Kostimulatorische blockade und gemischter chimerismus in allotransplantationen
Qin et al. Induction of classical transplantation tolerance in the adult.
Sorokin et al. Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats.
DE69533331T2 (de) Liganden zur induktion der antigen-spezifischen apoptose in t-zellen
DE69927520T2 (de) Verwendung von il-12 antikörpern zur behandlung von psoriasis
EP1483293A2 (de) Verwendung einer an cd28 bindenden wirksubstanz zur herstellung einer pharmazeutischen zusammensetzung
EP1600164A2 (de) Verwendung einer an CD28 bindenden Wirksubstanz zur Herstellung einer Pharmazeutischen Zusammensetzung mit dosisabhängiger Wirkung
DE69535713T2 (de) Verfahren zur modulierung von t-zellreaktionen durch manipulation einer gemeinsamen zytokinrezeptor-gammakette
EP1331944B1 (de) Verwendung cd28 spezifischer monoklonaler antikörper zur stimulation von blutzellen, welche kein cd28 tragen
DE69737888T2 (de) Anti-mhc klasse ii bindungsreagentien zur verwendung bei xenotransplantationen
Wasowska et al. The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses
Ochiai et al. Specificity and immunosuppressive potency of a rabbit antimouse T cell-specific antiserum
DE4312916C2 (de) Arzneimittel zur Behandlung von Immunreaktionen
DE4345200C2 (de) Hybridomzellen, die Antikörper bilden, die als Wirkstoff in Arzneimitteln zur Behandlung von Immunreaktionen enthalten sind
DE3626110A1 (de) Immunsuppressives serum
DE3919294C2 (de) Verwendung eines monoklonalen Antikörpers zur Behandlung einer Autoimmunerkrankung
DE69816812T2 (de) Non myeloablative therapie für toleranzinduktion

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee